Spontaneous cannabinoid withdrawal produces a differential time-related responsiveness in cannabinoid CB1 receptor gene expression in the mouse brain

Journal of Psychopharmacology

Volumn 18, Issue 1, 2004, Pages 59-65

  Oliva, José M ^a   Ortiz, Sergio ^a   Palomo, Tomás ^a   Manzanares, Jorge ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cannabinoids; Gene expression; MRNA; Withdrawal

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID 1 RECEPTOR;

ABSTINENCE; ADAPTATION; AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DRUG TOLERANCE; DRUG WITHDRAWAL; GENE EXPRESSION; GROOMING; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PUTAMEN; REARING; RECEPTOR UPREGULATION; TIME; WET DOG SHAKES; WITHDRAWAL SYNDROME;

ANIMALS; BRAIN; CANNABINOIDS; CYCLOHEXANOLS; DRUG TOLERANCE; MALE; MICE; MOTOR ACTIVITY; ORGAN SPECIFICITY; RECEPTOR, CANNABINOID, CB1; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; UP-REGULATION;

EID: 2442607835     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881104040238     Document Type: Article

References (24)

1. Abood M E, Martin B R (1992) Neurobiology of marijuana abuse. Trends Pharmacol Sci 13: 201-207
2. Aceto M D, Scates S M, Lowe J A, Martin B R (1996) Dependence on delta-9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther 278: 1290-1295
3. Aceto M D, Scates S M, Martin B R (2001) Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2. Eur J Pharmacol 416: 75-81
4. 9-tetrahydrocannabinol withdrawal. Eur J Pharmacol 387: 47-53
5. 9-tetrahydrocannabinol. J Pharmacol Exp Ther 285: 1150-1156
6. Costa B, Giagnoni G, Colleoni M (2000) Precipitated and spontaneous withdrawal in rats tolerant to anandamide. Psychopharmacology 149: 121-128
7. Diana M, Melis M, Muntoni A L, Gessa G L (1998) Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc Natl Acad Sci USA 95: 10269-10273
8. Doherty J, Dingledine R (2003) Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system. Curr Opin Pharmacol 3: 46-53
9. Gonzalez S, Manzanares J, Berrendero F, Wenger T, Corchero J, Bisogno T, Romero J, Fuentes J A, Di Marzo V, Ramos J A, Fernandez-Ruiz J (1999) Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland. Neuroendocrinology 70: 137-145
10. Hutcheson D M, Tzavara E T, Smadja C, Valjent E, Roques B P, Hanoune J, Maldonado R (1998) Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol. Br J Pharmacol 125: 1567-1577
11. Jones R T, Benowitz N, Bachman J (1976) Clinical studies of cannabis tolerance and dependence. Ann NY Acad Sci 282: 221-239
12. Jones R T, Benowitz N L, Herning R I (1981) Clinical relevance of cannabis tolerance and dependence. J Clin Pharmacol 21: 143S-152S
13. Lichtman A H, Sheikh S M, Loh H H, Martin B R (2001) Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. J Pharmacol Exp Ther 298: 1007-1014
14. Nestler E J (2002) Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Memory 78: 637-647
15. Paxinos G, Franklin K (2001) The mouse brain in stereotaxic coordinates. Academic Press, San Diego, CA
16. Rodriguez de Fonseca F, Gorriti M A, Fernandez-Ruiz, J J, Palomo T, Ramos J A (1994) Downregulation of rat brain cannabinoid binding sites after chronic delta-9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 47: 33-40
17. Romero J, Berrendero F, Manzanares J, Perez, A., Corchero J, Fuentes J A, Fernandez-Ruiz J J, Ramos J A (1998) Time course of the cannabinoid receptor down regulation in the adult rat brain caused by repeated exposure to delta-9-tetrahydrocannabinol. Synapse 30: 298-308
18. Rubino T, Patrini G, Massi P, Fuzio D, Vigano D, Giagnoni G, Parolaro D (1998) Cannabinoid-precipitated withdrawal: a time course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J Pharmacol Exp Ther 285: 813-819
19. Rubino T, Vigano D, Massi P, Parolaro D (2000) Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55 940. J Neurochem 75: 2080-2086
20. 35S]-GTPγS autoradiography in rat brain. J Neurosci 16: 8057-8066
21. Tsou K, Patrick S L, Walker J M (1995) Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur J Pharmacol 280: R13-R15
22. Vizi E S, Kiss J P (1998). Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and non-synaptic interactions. Hippocampus 8: 566-697
23. Wiesbeck G A, Schuckit M A, Kalmijn J A, Tipp J E, Bucholz K K, Smith T L (1996) An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 91: 1469-1478
24. Young S III, Bonner T, Brann M (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83: 9827-9831